Welcome to our dedicated page for Paysign SEC filings (Ticker: PAYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paysign, Inc. filings document formal disclosures for a Nevada public company providing patient affordability programs, donor compensation solutions, engagement and management platforms, and integrated payment processing. Recent Form 8-K reports furnish operating results and financial-condition updates tied to quarterly and annual earnings releases.
The company’s proxy materials describe annual meeting matters, director elections, auditor ratification, board and committee responsibilities, executive compensation, and beneficial ownership of Paysign securities. Other current reports include Regulation FD disclosures related to stockholder derivative action settlement materials, giving the filing record governance, litigation, ownership and reporting-context coverage in addition to financial results.
Paysign, Inc. EVP of Operations and director Joan M Herman reported open-market sales of a total of 59,904 shares of common stock on July 15–16, 2026, at weighted average prices of $8.5962 and $8.6932 per share. Following these transactions, Herman holds 647,105 shares directly. The sales were effected under a Rule 10b5-1 trading plan adopted on September 12, 2025.
Paysign, Inc. executive vice president of operations Joan M. Herman reported an open-market sale of 100,000 shares of common stock at a weighted average price of $8.0114 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 12, 2025.
After this sale, Herman directly holds 707,009 shares of Paysign common stock. Because the sale occurred pursuant to a Rule 10b5-1 plan, it appears to be part of a scheduled diversification or liquidity program rather than a discretionary one-time trade.
Paysign, Inc. Chief Legal Officer Robert Strobo reported routine equity compensation activity and related tax withholding. On November 13, 2025, he acquired 200,000 shares of common stock as a performance-based restricted stock award, granted May 7, 2025 after an earnings target was achieved. This restricted stock vests in three equal installments on May 27, 2026, May 24, 2027, and May 26, 2028, contingent on his continued service. On May 27, 2026, 39,235 shares of common stock were withheld by Paysign to cover tax obligations tied to the vesting of this restricted stock. After these transactions, Strobo directly owned 488,055 shares of Paysign common stock.
Paysign, Inc.’s Chief Financial Officer Jeffery Bradford Baker reported equity compensation activity and related tax withholding in company stock. On November 13, 2025, he acquired 200,000 shares of common stock as a performance-based restricted stock award at $0.00 per share, following achievement of a specified earnings target. This award will vest in three equal installments on May 29, 2026, May 20, 2027, and May 30, 2028, subject to his continued service. On May 29, 2026, 44,541 shares of common stock were withheld by the issuer to cover tax obligations tied to the vesting of restricted stock, leaving him with 541,677 shares of common stock held directly after that transaction. The filing reflects routine compensation and tax-withholding events rather than open-market buying or selling.
Paysign, Inc. director and EVP of Operations Joan M. Herman reported an open-market sale of 22,534 shares of common stock at a weighted average price of $7.0133 per share on May 26, 2026. After this transaction, Herman directly holds 836,211 Paysign shares.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan, meaning the trades were scheduled in advance rather than timed discretionarily.
Paysign, Inc. CEO Mark Newcomer reported routine equity compensation activity. He received a grant of 400,000 shares of performance-based restricted stock on November 13, 2025, after an earnings target was achieved. As part of the vesting on May 20, 2026, 78,701 shares were withheld at $6.15 per share to cover tax obligations, leaving him with 9,272,027 common shares held directly.
Paysign, Inc. executive Joan M. Herman reported routine equity compensation activity and related tax withholding. On May 13, 2026, 6,171 shares of common stock were withheld at $5.83 per share to cover tax obligations from restricted stock vesting, leaving her with 858,745 directly held shares. Earlier, on November 13, 2025, she received a grant of 33,333 performance-based restricted shares at no cost, tied to an earnings target, scheduled to vest in thirds annually from 2026 through 2028, contingent on continued service.
Paysign, Inc. Chief Payments Officer Matthew Louis Lanford reported routine equity compensation activity. He received a grant of 66,666 shares of performance-based restricted stock, with the performance goal deemed satisfied on November 13, 2025 based on a specified earnings target.
The restricted stock is scheduled to vest in three equal installments on May 18, 2026, May 18, 2027, and May 18, 2028, subject to continued service. On May 18, 2026, 12,755 shares of common stock were withheld by Paysign to cover tax obligations tied to vesting, leaving Lanford with 234,609 shares held directly.
Paysign, Inc. filing shows a proposed sale of 10,000 shares of Common Stock by Bruce A. Mina via a Form 144 dated 05/29/2026, with a reported aggregate sale amount of $71,900. The filing lists multiple prior restricted stock settlements awarded to the company and shows a prior sale of 10,000 shares on 06/13/2026 in the broker rows. The securities listed originate from compensatory restricted stock grants dated between 03/29/2018 and 09/11/2024.
Paysign, Inc. executive Joan M. Herman, EVP of Operations and a director, sold 29,202 shares of common stock in an open-market transaction at a weighted average price of $8.0039 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, and Herman now holds 807,009 shares directly.